Hilary Bernstein

Concepts (72)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Dexmethylphenidate Hydrochloride
3
2017
12
0.380
 Why?
Methylphenidate
3
2017
97
0.350
 Why?
Electroconvulsive Therapy
5
2010
402
0.240
 Why?
Ethanol
3
2017
893
0.240
 Why?
Milk Thistle
2
2014
7
0.150
 Why?
Silymarin
2
2014
7
0.140
 Why?
Central Nervous System Stimulants
2
2017
221
0.140
 Why?
Depressive Disorder
3
2005
621
0.140
 Why?
Nortriptyline
3
2010
28
0.120
 Why?
Cytochrome P-450 Enzyme Inhibitors
1
2014
12
0.120
 Why?
Cytochrome P-450 Enzyme System
1
2014
62
0.120
 Why?
Affect
1
2015
218
0.120
 Why?
Depressive Disorder, Major
2
2010
439
0.110
 Why?
Flavonolignans
1
2013
2
0.110
 Why?
Plant Extracts
1
2014
122
0.110
 Why?
Antioxidants
1
2013
304
0.090
 Why?
Lithium Compounds
1
2010
15
0.090
 Why?
Memory
1
2010
214
0.080
 Why?
Cross-Over Studies
2
2017
260
0.070
 Why?
Healthy Volunteers
2
2017
78
0.060
 Why?
Antidepressive Agents
1
2006
216
0.060
 Why?
Somatoform Disorders
1
2004
35
0.060
 Why?
Suicide
1
2005
116
0.060
 Why?
Young Adult
4
2017
5717
0.060
 Why?
Male
10
2017
37321
0.050
 Why?
Female
10
2017
38074
0.050
 Why?
Adult
8
2017
21403
0.050
 Why?
Anxiety
1
2004
422
0.050
 Why?
Psychiatric Status Rating Scales
3
2010
782
0.040
 Why?
Treatment Outcome
5
2010
7029
0.040
 Why?
Biological Availability
1
2017
79
0.040
 Why?
Humans
10
2017
68618
0.040
 Why?
Drug Interactions
1
2017
289
0.030
 Why?
Administration, Oral
1
2017
411
0.030
 Why?
Combined Modality Therapy
2
2010
951
0.030
 Why?
Drug Synergism
1
2015
260
0.030
 Why?
Tolbutamide
1
2014
5
0.030
 Why?
Herb-Drug Interactions
1
2014
5
0.030
 Why?
Dextromethorphan
1
2014
5
0.030
 Why?
Midazolam
1
2014
46
0.030
 Why?
Caffeine
1
2014
81
0.030
 Why?
F2-Isoprostanes
1
2013
14
0.030
 Why?
Dinoprost
1
2013
27
0.030
 Why?
Carboxylesterase
1
2012
4
0.030
 Why?
Esterification
1
2012
25
0.030
 Why?
Stereoisomerism
1
2012
169
0.030
 Why?
Area Under Curve
1
2012
238
0.030
 Why?
Severity of Illness Index
2
2010
1851
0.030
 Why?
Dietary Supplements
1
2014
332
0.020
 Why?
Middle Aged
5
2010
21147
0.020
 Why?
Hemodynamics
1
2012
705
0.020
 Why?
Aged, 80 and over
2
2010
4848
0.020
 Why?
Drug Therapy, Combination
1
2010
649
0.020
 Why?
Neuropsychological Tests
1
2010
517
0.020
 Why?
Aged
3
2010
14862
0.020
 Why?
Lithium Carbonate
1
2006
31
0.020
 Why?
Patient Dropouts
1
2006
98
0.020
 Why?
Adolescent
2
2010
8912
0.020
 Why?
Functional Laterality
1
2006
240
0.020
 Why?
Secondary Prevention
1
2006
291
0.020
 Why?
Lithium
1
2005
76
0.020
 Why?
Remission Induction
1
2004
111
0.020
 Why?
Proportional Hazards Models
1
2006
792
0.020
 Why?
Ambulatory Care
1
2006
340
0.010
 Why?
Research Design
1
2006
729
0.010
 Why?
Incidence
1
2005
1603
0.010
 Why?
Prognosis
1
2004
2093
0.010
 Why?
Follow-Up Studies
1
2004
3259
0.010
 Why?
Prospective Studies
1
2004
3705
0.010
 Why?
Surveys and Questionnaires
1
2004
2800
0.010
 Why?
Time Factors
1
2004
4655
0.010
 Why?
Risk Factors
1
2005
5731
0.010
 Why?
Bernstein's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (72)
Explore
_
Co-Authors (6)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_